Category: Press Release - Page 70 - Psychedelic Alpha

Read more about the article Mydecine Reports Positive Pre-IND Meeting With FDA For MYCO-001 Smoking Cessation Study

Mydecine Reports Positive Pre-IND Meeting With FDA For MYCO-001 Smoking Cessation Study

Post published:March 1, 2022
Post category:Press Release

Numinus Wellness Announces Voting Results From its Annual General and Special Meeting of Shareholders

Post published:February 28, 2022
Post category:Press Release

Read more about the article HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research

HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research

Post published:February 24, 2022
Post category:Press Release

Read more about the article Lobe Sciences Ltd. Strengthens Its Balance Sheet

Lobe Sciences Ltd. Strengthens Its Balance Sheet

Post published:February 24, 2022
Post category:Press Release

Read more about the article Entheon Biomedical Announces EBIQ-101 First-Patient Dose

Entheon Biomedical Announces EBIQ-101 First-Patient Dose

Post published:February 24, 2022
Post category:Press Release

Read more about the article COMPASS Pathways announces financial results for the fourth quarter and full year 2021 and business highlights

COMPASS Pathways announces financial results for the fourth quarter and full year 2021 and business highlights

Post published:February 24, 2022
Post category:Press Release

Read more about the article MindMed Converts Multiple Voting Shares to Subordinate Voting Shares

MindMed Converts Multiple Voting Shares to Subordinate Voting Shares

Post published:February 23, 2022
Post category:Press Release

Read more about the article PharmaDrug Receives Positive Results for DMT-Analogue Program to Treat Glaucoma

PharmaDrug Receives Positive Results for DMT-Analogue Program to Treat Glaucoma

Post published:February 23, 2022
Post category:Press Release

Read more about the article Filament Health and ATMA Journey Centers Announce Licensing Agreement

Filament Health and ATMA Journey Centers Announce Licensing Agreement

Post published:February 23, 2022
Post category:Press Release

Read more about the article World’s First Clinical Trial for DMT-Assisted Therapy in Major Depressive Disorder Shows Consistent Quality of Psychedelic Response in Phase I

World’s First Clinical Trial for DMT-Assisted Therapy in Major Depressive Disorder Shows Consistent Quality of Psychedelic Response in Phase I

Post published:February 22, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.